| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 05/15/2008 | WO2008055970A2 Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol |
| 05/15/2008 | WO2008055814A2 Process for the preparation of (s)-4-fluoromethyl-dihydro-furan-2-one |
| 05/15/2008 | WO2008055808A1 Indole and benzofuran 2-carboxamide derivatives |
| 05/15/2008 | WO2008008660B1 Cyclopentane derivatives as antiglaucoma agents |
| 05/15/2008 | WO2007138112A3 Compounds that interact with ion channels, in particular with ion channels from the kv family |
| 05/15/2008 | US20080114059 Novel Compounds For Treatment of Cardiac Arrhythmia and Methods of Use |
| 05/15/2008 | US20080114047 Mycobacterium tuberculosis infection; protozoan pathogens; fungal pathogens; 2-((4-Amidinobenzofuran-2-yl)methyl)benzofuran-4-carboxamidine; 4,5-Dihydro-2-(2-(2-(5-(4,5-dihydro-1H-imidazol-2-yl)benzofuran-2-yl)ethyl)benzofuran-5-yl)-1H-imidazole |
| 05/15/2008 | US20080114031 1,2;5,6-Di-O-isopropylidene-3-deoxy-3-[{(4-chloro-phenyl)amino}-carbonyl]-amino- alpha -D-allofuranoside; |
| 05/15/2008 | US20080113975 Thiourea compounds |
| 05/15/2008 | US20080113968 Substituted piperazines and diazepanes |
| 05/15/2008 | US20080113923 cubic liquid crystal formulation containing an amphiphilic compound such as 1-O-(5,9,13-trimethyltetradecyl)erythritol and a drug ( excluding a lysosomal enzyme) or cosmetic embedded in the cubic liquid crystal; time release agent |
| 05/15/2008 | US20080111478 Anthracene derivatives containing either a carbazole ring, a diphenylfuran ring or a diphenylthiaphene ring are capable of improving the driving voltage, efficiency, and color purity characteristics of an OLED |
| 05/15/2008 | US20080110763 electrolysis of 2-butene-1,4-diol to 2,5-dihydroxy-2,5-dihydrofuran and methylation to 2,5-dimethoxy-2,5-dihydrofuran; 1,3-dimethoxy-1,3-dihydroisobenzofuran from 1,2-benzenedimethanol; high yields and good selectivity; electrochemical oxidation in the presence of a C1 to C6 monoalkyl alcohol |
| 05/15/2008 | CA2669014A1 Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol |
| 05/15/2008 | CA2668959A1 Indole and benzofuran 2-carboxamide derivatives |
| 05/15/2008 | CA2667679A1 Process for the preparation of (s)-4-fluoromethyl-dihydro-furan-2-one |
| 05/15/2008 | CA2667644A1 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 05/14/2008 | EP1575922B1 Biphenyl derivatives and their use as fungicides |
| 05/14/2008 | EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/14/2008 | CN101180283A Dihydrobenzofuran derivatives and uses thereof |
| 05/14/2008 | CN101180282A Preparation of (s)-4-fluoromethyl-dihydro-furan-2-one |
| 05/14/2008 | CN101177385A Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease |
| 05/14/2008 | CN100387604C Triptolide purification method |
| 05/14/2008 | CN100387585C Tanshinone I derivatives and pharmaceutical application thereof |
| 05/13/2008 | US7371893 Passing o-xylene and/or naphthalene and oxygen over vanadium oxide, titanium dioxide and antimony oxide catalyst beds at a temperature of from 300 to 450 degrees C. to produce phthalic anhydride; high yield over longer periods of time |
| 05/13/2008 | US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action |
| 05/13/2008 | US7371774 Benzofurans and benzothiophenes |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/13/2008 | US7371420 Method for producing an avocado unsaponifiable rich in furan lipids |
| 05/13/2008 | US7371396 Dermatological and cosmetic compositions |
| 05/13/2008 | CA2322746C Method for distilling mixtures containing butanediol |
| 05/13/2008 | CA2263348C Pharmaceutical composition containing 4-oxo-butynic acids |
| 05/08/2008 | WO2008054804A2 Hydroxymethyl furfural oxidation methods |
| 05/08/2008 | WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 05/08/2008 | WO2008053437A2 A method for preparing ascorbic acid or a salt thereof from plant matrices |
| 05/08/2008 | WO2008053206A2 Process for preparation of aldonic acids and derivatives thereof |
| 05/08/2008 | WO2008024302A8 Compounds for treating proliferative disorders |
| 05/08/2008 | WO2008008718B1 Cyclopentane derivatives as antiglaucoma agents |
| 05/08/2008 | WO2008003637A3 Isolation and use of amine salts of mycophenolic acid |
| 05/08/2008 | WO2007133781A3 Furanone-initiated polymers |
| 05/08/2008 | US20080108840 Useful for inhibiting the aggregation of amyloid protein to form amyloid deposit |
| 05/08/2008 | US20080108839 Reduces the operating voltage and inhibits the molecules from being crystallized by using an aromatic amine derivative having an oxygen substituent for a hole transporting material; enhances yield in device, improves lifetime |
| 05/08/2008 | US20080108837 Separating a terpene trilactone from Ginkgo biloba plant material; column chromatography; large-scale isolation of ginkgolides as phytopharmaceuticals |
| 05/08/2008 | US20080108836 Method For Producing Alkenyl Succinic Anhydrides |
| 05/08/2008 | US20080108816 Process for the preparation of (s)-4-fluoromethyl-dihydro-furan-2-one |
| 05/08/2008 | US20080108813 Process for the preparation of 7-substituted 3-alkyl-3h-isobenzofuran-1-one derivatives |
| 05/08/2008 | US20080108662 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 05/08/2008 | US20080108601 anticancer agents; catalytic hydrogenation |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1917323A1 Novel materials for organic electroluminescent devices |
| 05/07/2008 | EP1917260A2 Process to obtain dibenzylbutyrolactonic, tetrahydrofuranic lignans and their synthetic and semi-synthetic derivatives, their analgesic and anti-inflammatory activities, topical and/or systemic formulations containing said lignans and their respective therapeutic method |
| 05/07/2008 | EP1558597B1 Continuous process for the production of optically pure (s)-beta hydroxy-gamma-butyrolactone |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | CN101175740A Dihydrobenzofuran derivatives and uses thereof |
| 05/07/2008 | CN101175720A New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 05/07/2008 | CN101175718A Processes for preparing biaryl ureas and analogs thereof |
| 05/07/2008 | CN101172980A Method for the preparation of hexahydro-furo 2,3-b furan-3-ol |
| 05/07/2008 | CN100386321C Y-type second-order non-linear optical luminophor contg. triphenylamine, prepn. method and use thereof |
| 05/07/2008 | CN100386316C Mixtures and compounds from Antrodia camphorate myceliums and use thereof |
| 05/06/2008 | US7368572 Anticancer agents |
| 05/06/2008 | US7368569 Combining a strong base with a phenyl isonicotinamide in aprotic solvents to form a solutions, then reacting with a cyclohexanone carboxylic acid or ester and water, and acidifying the solution to obtain chemical intermediates for neuropeptide Y antagonists used for treating bulimia, obesity or diabetes |
| 05/06/2008 | US7368477 Benzofuranyl alkanamine derivatives and uses thereof |
| 05/06/2008 | US7368476 4-{2-[3-benzofuran-2-yl-4-(2-pyrrolidin-1-ylethoxy)but-2-enoylamino]-ethoxy}-N-hydroxybenzamide hydrochloride; anticancer, bipolar disorders; inhibitors of histone deacetylase |
| 05/06/2008 | US7368475 high and selective activity against Cytomegalovirus |
| 05/06/2008 | US7368473 Paclitaxel enhancer compounds |
| 05/06/2008 | US7368472 1,2,4-Triaminobenzene derivatives useful for treating disorders of the central nervous system |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2244979C Proton conductor in liquid form |
| 05/02/2008 | WO2008050730A1 Process for producing ester compound |
| 05/02/2008 | WO2008049585A1 Pyridazine derivatives |
| 05/02/2008 | WO2007135293A3 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same |
| 05/02/2008 | CA2667235A1 Pyridazine derivatives |
| 05/01/2008 | US20080103318 Hydroxymethyl Furfural Oxidation Methods |
| 05/01/2008 | US20080103317 Processes for preparation of crystalline mycophenolate sodium |
| 05/01/2008 | US20080103316 Reduction of 4-aryl-4-ketobutanoic acid derivatives utilizing ruthenium containing catalysts |
| 05/01/2008 | US20080103196 19-hydroxylabda-8(17)-en-16,15-olide; mushroom extraction; MTT assay; neuroprotectant; cortical neuron damages, Alzheimer's disease; analgesic, antiinflammatory,anticarcinogenic, hypotensive agent |
| 05/01/2008 | US20080103191 Entacapone-derivatives |
| 05/01/2008 | US20080100207 cyclopentaphenanthrene-based compound which is adapted for both dry and wet processes, and has excellent thermal stability and good charge transport and emission characteristics |
| 04/30/2008 | EP1916240A1 Pyridazine derivatives |
| 04/30/2008 | EP1915357A1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor |
| 04/30/2008 | CN101171231A Diacylglycerol acyltransferase inhibitors |
| 04/30/2008 | CN101171230A Heterocyclic-substituted alkanamides useful as renin inhibitors |
| 04/30/2008 | CN101171223A Catalytic scriabine reaction |
| 04/30/2008 | CN101168539A Method for extracting salvianolic acid B and hydroxysafflor Yellow A and preparation method of Danhong for injection |
| 04/30/2008 | CN101168538A Annonaceousacetogenins compounds and preparation method thereof |
| 04/30/2008 | CN101168537A Method for simultaneously preparing andrographolide and dehydrated andrographolide |
| 04/30/2008 | CN101168536A Method for producing tetrahydrofuran |
| 04/30/2008 | CN101168535A One-step preparation method for tetrahydrofuran by gas phase hydrogenating maleic anhydride on Cu-Zn-Ti-Ge and using n-butylalcohol as solvent |
| 04/30/2008 | CN100384830C Derivative of cyclo membranousol kind and application thereof |
| 04/30/2008 | CN100384821C Cetp activity inhibitors |
| 04/29/2008 | US7365222 Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials |
| 04/29/2008 | US7365216 Process for the production of citalopram |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365094 Rheumatic diseases; antiarthritic agents; autoimmune disorders ; antiproliferative agents; antiinflammatory agents; antiprotozoa agents |
| 04/29/2008 | US7365091 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX |
| 04/29/2008 | US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 04/29/2008 | US7365076 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | US7364823 Amine compound, electrophotographic photoreceptor using the amine compound and image forming apparatus having the same |